Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natsuko Macabuag

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 30, 2015
Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein MotifsNatsuko Macabuag, Annette C Dolphin
Expert Opinion on Drug Discovery|November 21, 2022
RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotidesBlanca Torroba, Natsuko Macabuag, Elisabeth M Haisma, et al.
Journal of Medicinal Chemistry|May 4, 2026
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein DegradersDaniel T Webb, Katherine L Jones, Natsuko Macabuag, et al.
Journal of Medicinal Chemistry|September 13, 2022
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease PathologyNatsuko Macabuag, William Esmieu, Perla Breccia, et al.
Journal of Medicinal Chemistry|September 15, 2023
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's DiseaseLongbin Liu, Karine Malagu, Alan F Haughan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 30, 2015
Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein MotifsNatsuko Macabuag, Annette C Dolphin
Expert Opinion on Drug Discovery|November 21, 2022
RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotidesBlanca Torroba, Natsuko Macabuag, Elisabeth M Haisma, et al.
Journal of Medicinal Chemistry|May 4, 2026
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein DegradersDaniel T Webb, Katherine L Jones, Natsuko Macabuag, et al.
Journal of Medicinal Chemistry|September 13, 2022
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease PathologyNatsuko Macabuag, William Esmieu, Perla Breccia, et al.
Journal of Medicinal Chemistry|September 15, 2023
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's DiseaseLongbin Liu, Karine Malagu, Alan F Haughan, et al.
Pageof 1